Consolidated Statements of Cash Flows - USD ($) $ in Thousands	8 Months Ended	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2017
Net cash used in operating activities
Net loss	$ (264)	$ (1,143)
Share based compensation expenses	36	106
Decrease in other accounts receivable and prepaid expenses	(28)	7
Decrease in accrued expenses and other payables	(20)	(5)
Change in the fair value of derivative warrant liability		109
Net cash used in operating activities	(276)	(926)
Cash flows from financing activities
Exercise of options			[1]
Issuance of common stock, preferred stock and warrants	608	544
Acquisition of subsidiary in connection with a reverse acquisition	575
Cash flows from financing activities	1,183	544
Increase (decrease) in cash and cash equivalents	907	(382)
Cash and cash equivalents at the beginning of the period		907
Cash and cash equivalents at the end of the period	$ 907	$ 525

[1] Represents an amount lower than 1,000 USD